![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/09/2927684/0/en/Zentalis-Pharmaceuticals-Reports-Second-Quarter-2024-Financial-Results-and-Operational-Progress.html
https://www.globenewswire.com/news-release/2024/08/01/2923316/0/en/Zentalis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/07/01/2907101/0/en/Zentalis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.biospace.com/article/zentalis-hit-with-fda-partial-clinical-hold-on-three-cancer-studies-following-two-patient-deaths-/
https://www.globenewswire.com/news-release/2024/06/03/2892665/0/en/Zentalis-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/30/2890608/0/en/Zentalis-Pharmaceuticals-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/29/2889696/0/en/Zentalis-Pharmaceuticals-Announces-Appointment-of-Accomplished-Oncology-Drug-Developer-Luke-Walker-M-D-to-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/05/23/2887695/0/en/Zentalis-Pharmaceuticals-to-Present-Promising-Results-from-Phase-1-Trial-of-Azenosertib-and-Gemcitabine-in-Relapsed-or-Refractory-Osteosarcoma-at-2024-American-Society-of-Clinical-.html
https://www.globenewswire.com/news-release/2024/05/14/2881203/0/en/Zentalis-Pharmaceuticals-to-Present-at-TD-Cowen-5th-Annual-Oncology-Innovation-Summit.html
https://www.globenewswire.com/news-release/2024/05/07/2876560/0/en/Zentalis-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results-and-Operational-Progress.html